Literature DB >> 18927997

23-valent pneumococcal polysaccharide vaccine. WHO position paper.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18927997

Source DB:  PubMed          Journal:  Wkly Epidemiol Rec        ISSN： 0049-8114


× No keyword cloud information.
  73 in total

Review 1.  Vaccination of adolescents with chronic medical conditions: Special considerations and strategies for enhancing uptake.

Authors:  Annika M Hofstetter; Philip LaRussa; Susan L Rosenthal
Journal:  Hum Vaccin Immunother       Date:  2015-07-25       Impact factor: 3.452

2.  [Vaccination against pneumococci and influenza. How good is the evidence?].

Authors:  B Babouee; A F Widmer; M Battegay
Journal:  Internist (Berl)       Date:  2011-03       Impact factor: 0.743

3.  Efficacy of pneumococcal polysaccharide vaccine.

Authors:  Pippa Scott; Anke Huss; Andreas E Stuck; Caroline Trotter; Matthias Egger
Journal:  CMAJ       Date:  2009-05-26       Impact factor: 8.262

4.  The controversy over the efficacy of pneumococcal vaccine.

Authors:  Ross Andrews; Sarah A Moberley
Journal:  CMAJ       Date:  2009-01-06       Impact factor: 8.262

5.  Primary care of adults with developmental disabilities: Canadian consensus guidelines.

Authors:  William F Sullivan; Joseph M Berg; Elspeth Bradley; Tom Cheetham; Richard Denton; John Heng; Brian Hennen; David Joyce; Maureen Kelly; Marika Korossy; Yona Lunsky; Shirley McMillan
Journal:  Can Fam Physician       Date:  2011-05       Impact factor: 3.275

6.  Safety and immunogenicity of 23-valent pneumococcal polysaccharide vaccine in 2 to 70 year old healthy people in China: A phase III double blind, randomized clinical trial.

Authors:  Guifan Li; Qi Liang; Jichun Shi; Yuemei Hu; Hong Li; Wenjin Wei; Fengcai Zhu; Qiang Ye
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

7.  Cost-effectiveness of polysaccharide pneumococcal vaccination in people aged 65 and above in Poland.

Authors:  Pawel Grzesiowski; Raquel Aguiar-Ibáñez; Aleksandra Kobryń; Laure Durand; Pierre-Emmanuel Puig
Journal:  Hum Vaccin Immunother       Date:  2012-10-01       Impact factor: 3.452

8.  Open-label trial of immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults ≥ 50 years of age in Mexico.

Authors:  Juan Carlos Tinoco; Christine Juergens; Guillermo M Ruiz Palacios; Jorge Vazquez-Narvaez; Hermann Leo Enkerlin-Pauwells; Vani Sundaraiyer; Sudam Pathirana; Elena Kalinina; William C Gruber; Daniel A Scott; Beate Schmoele-Thoma
Journal:  Clin Vaccine Immunol       Date:  2014-12-10

9.  A retrospective analysis of hospital discharge records for S. pneumoniae diseases in the elderly population of Florence, Italy, 2010-2012.

Authors:  Angela Bechini; Cristina Taddei; Alessandro Barchielli; Miriam Levi; Emilia Tiscione; Maria Grazia Santini; Fabrizio Niccolini; Maria Teresa Mechi; Donatella Panatto; Daniela Amicizia; Chiara Azzari; Paolo Bonanni; Sara Boccalini
Journal:  Hum Vaccin Immunother       Date:  2014-11-01       Impact factor: 3.452

10.  The effect of age on the response to the pneumococcal polysaccharide vaccine.

Authors:  Hyunju Lee; Moon H Nahm; Kyung-Hyo Kim
Journal:  BMC Infect Dis       Date:  2010-03-10       Impact factor: 3.090
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.